On 22nd March 2021, Taiwan FDA announced a plan on pilot testing of eCTD submission.
To ensure that the eCTD submission platform functions smoothly, Taiwan FDA will conduct pilot testing
On 22nd March 2021, Taiwan FDA announced a plan on pilot testing of eCTD submission.
To ensure that the eCTD submission platform functions smoothly, Taiwan FDA will conduct pilot testing
As part of the aim to facilitate the efficient development and timely registration of beneficial innovative therapeutic products (chemical and biologic compounds) and cell, tissue or gene therapy products (CTGTPs)
On 25th February 2021, the Medical Devices Branch (MDB) has introduced a new self-help tool to guide in grouping of medical devices for purposes of premarket registration. This medical device grouping tool will
New regulations came into effect on 15 February 2021 to harmonise Thailand’s Medical Device Act with the ASEAN Medical Device Directive.
In the past, a majority of the medical device are under the
The Ministry of Health Vietnam has issued on 03 February 2021, Official letter No. 777/QLD-DK regarding implementation of online system to maintain the validity of drug licences.
The Drug Administration of
Malaysia NPRA issues Directive 8 of 2021 on Strengthening of the Implementation of Products Regulatory Control – Medical Gas Products and the Use of Guideline on Registration of Medicinal Gases.
To
A new standard clarifying requirements for serialisation and data matrix codes on medicines supplied in Australia commences on 1 January 2023. The Therapeutic Goods (Medicines – Standard for Serialisation and
On 4 December 2020, the TGA inclusion process for Class 1 in vitro diagnostic (IVD) medical devices in the Australian Register of Therapeutic Goods (ARTG) changed. This follows similar changes
Singapore Health Sciences Authority has updated the Guidance for Industry: Product Defect Reporting and Recall Procedures for Therapeutic Products and Cells, Tissue and Gene Therapy Products (CTGTPs). The main updates